| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |